查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1954577

全球維生素 B12 市場：市場規模、佔有率、成長率、行業分析、依類型、應用和地區劃分的分析以及未來預測（2026-2034 年）

Vitamin B12 Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 100 Pages | 商品交期: 2-3個工作天內

價格

維生素 B12 市場成長因子

預計未來十年全球維生素 B12 市場將顯著成長。 2025年，該市場價值2.168億美元，預計2026年將成長至2.3億美元，到2034年將達到4.06億美元。這意味著2026年至2034年間的複合年增長率將達到7.4%。市場成長的驅動因素包括人們健康意識的提高、維生素B12缺乏症發病率的上升以及需要補充維生素B12的植物性飲食日益普及。 維生素B12（也稱為鈷胺素）是一種水溶性維生素，對DNA合成、紅血球生成、脂肪酸代謝和神經系統健康至關重要。維生素B12缺乏會導致貧血、神經系統症狀以及同型半胱胺酸和甲烷代謝紊亂。由於牛奶、肉類、雞蛋和魚類等動物產品是維生素B12的天然來源，因此素食者和純素食者尤其容易出現維生素B12缺乏，這進一步推動了對維生素B12補充劑和強化產品的需求。 市場驅動因素與成長因素

市場成長主要受全球維生素B12缺乏症和神經系統疾病日益增加的趨勢所驅動。人們對醫療保健的日益關注和健康意識的提高，推動了對營養補充劑和強化食品需求的激增。例如，2023年12月，Quadrum研究所和肯特大學共同開發了一種用於大規模生產鈷胺素的新型永續技術，該技術減少了氰化物和鈷的使用，提高了產品安全性和供應效率。

產品創新也促進了市場擴張。 2023年6月，寶潔公司旗下的VOOST品牌推出了石榴柑橘口味的維生素B12軟糖，旨在支持細胞能量和新陳代謝，這反映了消費者對口感極佳的營養補充劑的偏好。此外，新冠疫情也增加了消費者對包括維生素B12在內的免疫支持維生素的需求，因為他們需要營養補充。然而，由於前一年活性藥物成分（API）的囤積，2022年至2023年間市場經歷了輕微調整。 市場區隔 依類型劃分，氰鈷胺素憑藉其穩定性、易得性和成本效益，在2026年佔市場主導地位，市佔率達60.22%。它廣泛用於藥物製劑和強化食品。甲基鈷胺素位居第二，因其高生物利用度和神經系統作用而備受重視。腺苷鈷胺素和羥鈷胺素雖然市佔率較小，但由於生產技術的進步，正日益受到重視。 依應用劃分，預計食品級鈷胺素將在2026年佔市場主導地位，市佔率達81.83%。這主要得益於強化食品和功能性飲料消費量的成長。隨著週邊神經病變、黃斑部病變和萎縮性胃炎的盛行率上升，對鈷胺素補充劑的需求增加，預計醫藥級鈷胺素市場將穩定成長。

依終端用戶劃分，食品和營養補充劑行業預計將在2026年佔市場主導地位，市場佔有率達59.65%。這主要得益於消費者對富含營養的產品（如乳製品替代品、能量棒和強化飲料）的需求。製藥業也持續成長，尤其是在老年人維生素B12缺乏症高發地區，例如美國。在美國，60歲以上的成年人中有6%至20%受到影響。

區域洞察

亞太地區引領市場，預計2025年營收將達1.266億美元。這主要得益於糖尿病神經病變的高發生率、不斷增長的老齡人口以及中國、印度和東南亞地區對營養補充劑日益增長的認知。中國是氰鈷胺素最大的生產國和消費國，約佔全球產量的90%。

在歐洲，由於營養和健康領域的創新、監管支持以及惡性貧血的增加，預計市場將快速成長。預計到2026年，德國和英國市場將分別達到840萬美元和300萬美元。以美國為主導的北美市場預計到2026年將達到4,680萬美元，這主要得益於人們對預防性醫療保健意識的提高以及神經系統疾病的增加。其他地區（ROW）預計將實現溫和成長，這主要得益於宣傳活動和應對微量營養素缺乏症的努力。

主要公司及趨勢

主要公司包括 Euroapi（法國）、石藥集團（中國）、寧夏金比特藥業（中國）、Pharmavit（荷蘭）和中藥國際集團（中國）。主要趨勢包括 Euroapi 於 2023 年 8 月在法國投資 2,500 萬美元建造生物質鍋爐，以擴大維生素 B12 的產能；以及 Lupin 於 2024 年 2 月在美國推出用於治療惡性貧血的氰鈷胺鼻噴霧劑。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：關鍵考慮因素

  • 主要地區監管環境概述
  • 主要產業趨勢（併購、業務合作等）
  • 新冠疫情對市場的影響

第五章 全球維生素B12市場分析：洞察與預測

（2021-2034）
  • 市場分析、洞察與預測：依類型劃分
    • 氰鈷胺素
    • 甲基鈷胺素
    • 腺苷鈷胺素
    • 羥鈷胺素
  • 市場分析、洞察與預測：依應用劃分
    • 食品級
    • 醫藥級
    • 飼料級
  • 市場分析、洞察與預測：依最終用戶劃分
    • 製藥業
    • 食品和膳食補充劑行業
    • 其他
  • 市場分析、洞察與預測：依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 其他地區（ROW）

第六章分析北美維生素 B12 市場：洞察與預測 (2021-2034)

  • 依國家劃分
    • 美國
    • 加拿大

第七章 歐洲維生素 B12 市場分析：洞察與預測 (2021-2034)

  • 依國家劃分
    • 德國
    • 法國
    • 西班牙
    • 英國
    • 義大利
    • 斯堪的納維亞
    • 其他歐洲國家

第八章 亞太地區維生素 B12 市場分析：洞察與預測 (2021-2034)

  • 依國家/地區
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 東南亞
    • 其他亞太地區

第九章：其他地區（ROW）維生素B12市場分析：洞察與預測（2021-2034）

第10章 競爭分析

  • 世界市場佔有率分析(2025年)
  • 企業簡介
    • EUROAPI
    • CSPC Pharmaceutical Group Co., Ltd.
    • Ningxia Kingvit Pharmaceutical
    • Pharmavit
    • NCPC INTERNATIONAL CORP.
Product Code: FBI104816

Growth Factors of vitamin B12 Market

The global vitamin B12 market is poised for significant growth over the next decade. Valued at USD 216.8 million in 2025, the market is projected to rise to USD 230 million in 2026 and reach USD 406 million by 2034, reflecting a robust CAGR of 7.4% from 2026 to 2034. The market's growth is fueled by increasing awareness of health and wellness, rising prevalence of vitamin B12 deficiencies, and the popularity of plant-based diets that necessitate supplementation.

Vitamin B12, also known as cobalamin, is a water-soluble vitamin critical for DNA synthesis, red blood cell formation, fatty acid metabolism, and neurological health. Its deficiency can lead to anemia, neurological symptoms, and impaired metabolism of homocysteine and methanoic acid. Animal-derived foods such as milk, meat, eggs, and fish are natural sources of vitamin B12, making vegetarians and vegans particularly susceptible to deficiencies, further driving demand for supplements and fortified products.

Market Drivers and Growth Factors

The market growth is primarily driven by the rising prevalence of vitamin B12 deficiency and neurological conditions worldwide. The trend toward preventive healthcare and increasing health awareness has led to a surge in demand for supplements and fortified foods. For instance, Quadram Institute and the University of Kent in December 2023 developed new sustainable technology for large-scale cobalamin production with reduced use of cyanide and cobalt, enhancing product safety and supply efficiency.

Product innovations also contribute to market expansion. In June 2023, Procter & Gamble's brand VOOST launched pomegranate citrus-flavored vitamin B12 gummies aimed at supporting cellular energy and metabolism, reflecting growing consumer preference for palatable supplement forms. Furthermore, the COVID-19 pandemic boosted demand for immune-supportive vitamins, including B12, as consumers sought nutritional interventions, although the market saw a slight correction in 2022-2023 due to prior stockpiling of APIs.

Market Segmentation

By type, cyanocobalamin dominated the market with 60.22% share in 2026 due to its stability, availability, and cost-effectiveness. It is widely used in pharmaceutical formulations and fortified foods. Methylcobalamin followed as the second-largest segment, appreciated for higher bioavailability and neurological benefits. Adenosylcobalamin and hydroxocobalamin hold smaller market shares but are gaining traction due to advancements in production technologies.

By application, the food grade segment led with an 81.83% share in 2026, driven by increased consumption of fortified foods and functional beverages. The pharmaceutical grade segment is expected to grow steadily due to rising prevalence of peripheral neuropathy, macular degeneration, and atrophic gastritis, necessitating cobalamin supplementation.

By end-user, the food & nutraceuticals industry dominated with a 59.65% share in 2026, fueled by demand for nutrition-rich products like dairy substitutes, energy bars, and fortified beverages. The pharmaceutical industry is growing as well, particularly in regions with high B12 deficiency rates among elderly populations, such as the U.S., where 6-20% of adults over 60 are affected.

Regional Insights

Asia Pacific led the market in 2025 with a revenue of USD 126.6 million, driven by high prevalence of diabetic neuropathy, increasing geriatric population, and growing awareness of dietary supplements in China, India, and Southeast Asia. China, as the largest producer and consumer of cyanocobalamin, accounts for nearly 90% of global production.

Europe is witnessing rapid growth due to innovation in nutrition and wellness sectors, regulatory support, and rising prevalence of pernicious anemia. Germany and the UK markets are projected to reach USD 8.4 million and USD 3 million, respectively, by 2026. North America's market, led by the U.S., is expected to reach USD 46.8 million in 2026, supported by preventive healthcare awareness and growing neurological conditions. The rest of the world sees gradual growth driven by awareness campaigns and efforts to combat micronutrient malnutrition.

Key Industry Players and Developments

Leading companies include EUROAPI (France), CSPC Pharmaceutical Holdings Co., Ltd. (China), Ningxia Kingvit Pharmaceutical (China), Pharmavit (Netherlands), and NCPC International Corp. (China). Notable developments include EUROAPI's USD 25 million biomass boiler investment in France (August 2023) to expand B12 production capacity and Lupin Limited's Cyanocobalamin Nasal Spray launch (February 2024) in the U.S. to address pernicious anemia.

Conclusion

The global vitamin B12 market is set for steady growth between 2025 and 2034. Rising health awareness, an aging population, growing prevalence of B12 deficiencies, and strategic product launches in pharmaceuticals and fortified foods are key growth drivers. While high dependency on China for supply and production costs may restrain growth, innovations in production technologies and bioavailable formulations are likely to sustain market expansion. With Asia Pacific at the forefront and Europe and North America showing promising growth, the global B12 market is evolving into a competitive and opportunity-rich industry.

Segmentation By Type

  • Cyanocobalamin
  • Methylcobalamin
  • Adenosylcobalamin
  • Hydroxocobalamin

By Application

  • Food Grade
  • Pharmaceutical Grade
  • Feed Grade

By End-user

  • Pharmaceutical Industry
  • Food & Nutraceuticals Industry
  • Others

By Region

  • North America (By Type, By Application, By End-user, By Country)
    • U.S.
    • Canada
  • Europe (By Type, By Application, By End-user, By Country)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Type, By Application, By End-user, By Country)
    • China
    • India
    • Japan
    • Australia
    • Southeast Asia
    • Rest of the Asia Pacific
  • Rest of the World (By Type, By Application, By End-user)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Overview Regulatory Scenario, By Key Regions
  • 4.2. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
  • 4.3. Impact of COVID-19 on the Market

5. Global Vitamin B12 Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Cyanocobalamin
    • 5.1.2. Methylcobalamin
    • 5.1.3. Adenosylcobalamin
    • 5.1.4. Hydroxocobalamin
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Food Grade
    • 5.2.2. Pharmaceutical Grade
    • 5.2.3. Feed Grade
  • 5.3. Market Analysis, Insights and Forecast - By End-user
    • 5.3.1. Pharmaceutical Industry
    • 5.3.2. Food & Nutraceuticals Industry
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Rest of the World

6. North America Vitamin B12 Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Cyanocobalamin
    • 6.1.2. Methylcobalamin
    • 6.1.3. Adenosylcobalamin
    • 6.1.4. Hydroxocobalamin
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Food Grade
    • 6.2.2. Pharmaceutical Grade
    • 6.2.3. Feed Grade
  • 6.3. Market Analysis, Insights and Forecast - By End-user
    • 6.3.1. Pharmaceutical Industry
    • 6.3.2. Food & Nutraceuticals Industry
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Vitamin B12 Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Cyanocobalamin
    • 7.1.2. Methylcobalamin
    • 7.1.3. Adenosylcobalamin
    • 7.1.4. Hydroxocobalamin
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Food Grade
    • 7.2.2. Pharmaceutical Grade
    • 7.2.3. Feed Grade
  • 7.3. Market Analysis, Insights and Forecast - By End-user
    • 7.3.1. Pharmaceutical Industry
    • 7.3.2. Food & Nutraceuticals Industry
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.4.1. Germany
    • 7.4.2. France
    • 7.4.3. Spain
    • 7.4.4. U.K.
    • 7.4.5. Italy
    • 7.4.6. Scandinavia
    • 7.4.7. Rest of Europe

8. Asia Pacific Vitamin B12 Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Cyanocobalamin
    • 8.1.2. Methylcobalamin
    • 8.1.3. Adenosylcobalamin
    • 8.1.4. Hydroxocobalamin
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Food Grade
    • 8.2.2. Pharmaceutical Grade
    • 8.2.3. Feed Grade
  • 8.3. Market Analysis, Insights and Forecast - By End-user
    • 8.3.1. Pharmaceutical Industry
    • 8.3.2. Food & Nutraceuticals Industry
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.4.1. Japan
    • 8.4.2. China
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Rest of the World Vitamin B12 Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Cyanocobalamin
    • 9.1.2. Methylcobalamin
    • 9.1.3. Adenosylcobalamin
    • 9.1.4. Hydroxocobalamin
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Food Grade
    • 9.2.2. Pharmaceutical Grade
    • 9.2.3. Feed Grade
  • 9.3. Market Analysis, Insights and Forecast - By End-user
    • 9.3.1. Pharmaceutical Industry
    • 9.3.2. Food & Nutraceuticals Industry
    • 9.3.3. Others

10. Competitive Analysis

  • 10.1. Global Market Share Analysis (2025)
  • 10.2. Company Profiles
    • 10.2.1. EUROAPI
      • 10.2.1.1. Overview
      • 10.2.1.2. Products
      • 10.2.1.3. SWOT Analysis
      • 10.2.1.4. Recent Developments
      • 10.2.1.5. Strategies
      • 10.2.1.6. Financials (Based on Availability)
    • 10.2.2. CSPC Pharmaceutical Group Co., Ltd.
      • 10.2.2.1. Overview
      • 10.2.2.2. Products
      • 10.2.2.3. SWOT Analysis
      • 10.2.2.4. Recent Developments
      • 10.2.2.5. Strategies
      • 10.2.2.6. Financials (Based on Availability)
    • 10.2.3. Ningxia Kingvit Pharmaceutical
      • 10.2.3.1. Overview
      • 10.2.3.2. Products
      • 10.2.3.3. SWOT Analysis
      • 10.2.3.4. Recent Developments
      • 10.2.3.5. Strategies
      • 10.2.3.6. Financials (Based on Availability)
    • 10.2.4. Pharmavit
      • 10.2.4.1. Overview
      • 10.2.4.2. Products
      • 10.2.4.3. SWOT Analysis
      • 10.2.4.4. Recent Developments
      • 10.2.4.5. Strategies
      • 10.2.4.6. Financials (Based on Availability)
    • 10.2.5. NCPC INTERNATIONAL CORP.
      • 10.2.5.1. Overview
      • 10.2.5.2. Products
      • 10.2.5.3. SWOT Analysis
      • 10.2.5.4. Recent Developments
      • 10.2.5.5. Strategies
      • 10.2.5.6. Financials (Based on Availability)

List of Tables

  • Table 01: Global Vitamin B12 Market Revenue (USD million) Forecast, By Type, 2021-2034
  • Table 02: Global Vitamin B12 Market Revenue (USD million) Forecast, By Application, 2021-2034
  • Table 03: Global Vitamin B12 Market Revenue (USD million) Forecast, By End-user, 2021-2034
  • Table 04: Global Vitamin B12 Market Revenue (USD million) Forecast, By Region, 2021-2034
  • Table 05: North America Vitamin B12 Market Revenue (USD million) Forecast, By Type, 2021-2034
  • Table 06: North America Vitamin B12 Market Revenue (USD million) Forecast, By Application , 2021-2034
  • Table 07: North America Vitamin B12 Market Revenue (USD million) Forecast, By End-user, 2021-2034
  • Table 08: North America Vitamin B12 Market Revenue (USD million) Forecast, By Country, 2021-2034
  • Table 09: Europe Vitamin B12 Market Revenue (USD million) Forecast, By Type, 2021-2034
  • Table 10: Europe Vitamin B12 Market Revenue (USD million) Forecast, By Application , 2021-2034
  • Table 11: Europe Vitamin B12 Market Revenue (USD million) Forecast, By End-user, 2021-2034
  • Table 12: Europe Vitamin B12 Market Revenue (USD million) Forecast, By Country/Sub-region, 2021-2034
  • Table 13: Asia Pacific Vitamin B12 Market Revenue (USD million) Forecast, By Type, 2021-2034
  • Table 14: Asia Pacific Vitamin B12 Market Revenue (USD million) Forecast, By Application, 2021-2034
  • Table 15: Asia Pacific Vitamin B12 Market Revenue (USD million) Forecast, By End-user, 2021-2034
  • Table 16: Asia Pacific Vitamin B12 Market Revenue (USD million) Forecast, By Country/sub-region, 2021-2034
  • Table 17: Rest of the World Vitamin B12 Market Revenue (USD million) Forecast, By Type, 2021-2034
  • Table 18: Rest of the World Vitamin B12 Market Revenue (USD million) Forecast, By Application, 2021-2034
  • Table 19: Rest of the World Vitamin B12 Market Revenue (USD million) Forecast, By End-user, 2021-2034

List of Figures

  • Figure 01: Global vitamin B12 Market Revenue Breakdown (USD million, %) by Region, 2025 & 2034
  • Figure 02: Global Vitamin B12 Market Value Share (%), By Type, 2025 & 2034
  • Figure 03: Global Vitamin B12 Market Value Share (%), By Application, 2025 & 2034
  • Figure 04: Global Vitamin B12 Market Value Share (%), By End-user, 2025 & 2034
  • Figure 05: Global Vitamin B12 Market Value (USD million), By Region, 2025 & 2034
  • Figure 06: North America Vitamin B12 Market Value (USD million), By Type, 2025 & 2034
  • Figure 07: North America Vitamin B12 Market Value Share (%), By Type, 2025
  • Figure 08: North America Vitamin B12 Market Value (USD million), By Application, 2025 & 2034
  • Figure 09: North America Vitamin B12 Market Value Share (%), By Application, 2025
  • Figure 10: North America Vitamin B12 Market Value (USD million), By End-user, 2025 & 2034
  • Figure 11: North America Vitamin B12 Market Value Share (%), By End-user, 2025
  • Figure 12: North America Vitamin B12 Market Value (USD million), by Country, 2025 & 2034
  • Figure 13: North America Vitamin B12 Market Value Share (%), by Country, 2025
  • Figure 14: Europe Vitamin B12 Market Value (USD million), By Type, 2025 & 2034
  • Figure 15: Europe Vitamin B12 Market Value Share (%), By Type, 2025
  • Figure 16: Europe Vitamin B12 Market Value (USD million), By Application, 2025 & 2034
  • Figure 17: Europe Vitamin B12 Market Value Share (%), By Application, 2025
  • Figure 18: Europe Vitamin B12 Market Value (USD million), By End-user, 2025 & 2034
  • Figure 19: Europe Vitamin B12 Market Value Share (%), By End-user, 2025
  • Figure 20: Europe Vitamin B12 Market Value (USD million), By Country/Sub-region, 2025 & 2034
  • Figure 21: Europe Vitamin B12 Market Value Share (%), By Country/Sub-region, 2025
  • Figure 22: Asia Pacific Vitamin B12 Market Value (USD million), By Type, 2025 & 2034
  • Figure 23: Asia Pacific Vitamin B12 Market Value Share (%), By Type, 2025
  • Figure 24: Asia Pacific Vitamin B12 Market Value (USD million), By Application, 2025 & 2034
  • Figure 25: Asia Pacific Vitamin B12 Market Value Share (%), By Application, 2025
  • Figure 26: Asia Pacific Vitamin B12 Market Value (USD million), By End-user, 2025 & 2034
  • Figure 27: Asia Pacific Vitamin B12 Market Value Share (%), By End-user, 2025
  • Figure 28: Asia Pacific Vitamin B12 Market Value (USD million), By Country/Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Vitamin B12 Market Value Share (%), By Country/Sub-region, 2025
  • Figure 30: Rest of the World Vitamin B12 Market Value (USD million), By Type, 2025 & 2034
  • Figure 31: Rest of the World Vitamin B12 Market Value Share (%), By Type, 2025
  • Figure 32: Rest of the World Vitamin B12 Market Value (USD million), By Application, 2025 & 2034
  • Figure 33: Rest of the World Vitamin B12 Market Value Share (%), By Application, 2025
  • Figure 34: Rest of the World Vitamin B12 Market Value (USD million), By End-user, 2025 & 2034
  • Figure 35: Rest of the World Vitamin B12 Market Value Share (%), By End-user, 2025
  • Figure 36: Global Vitamin B12 Market Share Analysis (%), By Company, 2025